Questions and answers on the outcome of an extension of indication application for Inovelon (rufinamide)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
variation-report
medication.label.permit_validity
First published: 2017-02-08T13:19:00Z
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live